The Federal Trade Commission on Tuesday ramped up the pressure on prescription-drug middlemen who influence the accessibility and affordability of medications.
More Stories
The Fed decision’s lone dissenter worries the bigger rate cut sends a ‘premature victory’ message to markets
Michelle Bowman was the first Federal Reserve governor to dissent from an interest-rate decision since 2005.
Tech giants desperate to power AI data centers are turning to nuclear disaster sites — despite the risks
The tech industry’s need for more power for data centers running artificial intelligence is now so desperate that companies are...
Jamie Dimon: Only 5% of everyday Americans probably know about the Fed’s historic interest-rate cut
JPMorgan Chase CEO Jamie Dimon suggests the half-point interest-rate cut is “a minor thing” that Wall Street — not Main...
Uranium ETFs rally amid plans to revive nuclear reactor in Microsoft agreement
Constellation Energy said Friday it plans to restart a nuclear reactor at Three Mile Island.
The Fed rate cut scared me. Where should I invest my $127,000 in savings now?
This reader wonders whether CD rates, high-yield savings accounts and bond ladders are still smart moves, even if interest rates...
The fan who caught Shohei Ohtani’s 50th home-run ball could make $500,000
Aaron Judge’s 62nd home-run ball in 2022 sold for $1.5 million at auction